NCT01692717View on ClinicalTrials.gov

Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy Subjects
Interventions
DRUG

Atorvastatin

10 mg

DRUG

Hydrochlorothiazide + Losartan

12.5 mg + 50 mg

DRUG

Hydrochlorothiazide + Losartan + Atorvastatin

12.5 mg + 50 mg + 10 mg

Trial Locations (1)

Unknown

LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos

All Listed Sponsors
lead

Azidus Brasil

INDUSTRY

NCT01692717 - Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide | Biotech Hunter | Biotech Hunter